Upexi, Inc.
Upexi, Inc. (UPXI) Financial Performance & Income Statement Overview
Review Upexi, Inc. (UPXI) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Upexi, Inc. (UPXI) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Upexi, Inc. UPXI financial performance.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $3.16M | $4.005M | $4.36M | -$33.59M |
| Cost of Revenue | $1.60M | $1.03M | $1.43M | -$29.69M |
| Gross Profit | $1.56M | $2.97M | $2.93M | -$7.04M |
| Gross Profit Ratio | $0.49 | $0.74 | $0.67 | $0.21 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.68M | $3.81M | $4.006M | $1.95M |
| Operating Expenses | $3.68M | $4.05M | $4.27M | $10.60M |
| Total Costs & Expenses | $5.28M | $5.08M | $5.69M | -$19.09M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | -$245103.00 | $0.00 | $290412.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $239752.00 | $259095.00 | $919697.00 |
| EBITDA | -$3.59M | -$833447.00 | -$1.08M | -$24.36M |
| EBITDA Ratio | -$1.14 | -$0.21 | -$0.25 | $0.73 |
| Operating Income | -$3.59M | -$1.07M | -$1.34M | -$14.60M |
| Operating Income Ratio | -$1.14 | -$0.27 | -$0.31 | $0.43 |
| Other Income/Expenses (Net) | -$244427.00 | -$228111.00 | -$290412.00 | -$476251.00 |
| Income Before Tax | -$3.83M | -$1.30M | -$1.63M | -$14.86M |
| Income Before Tax Ratio | -$1.21 | -$0.32 | -$0.37 | $0.44 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $2.34M |
| Net Income | -$3.83M | -$1.30M | -$1.63M | -$15.75M |
| Net Income Ratio | -$1.21 | -$0.32 | -$0.37 | $0.47 |
| EPS | -$2.87 | -$1.24 | -$1.55 | -$15.33 |
| Diluted EPS | -$2.87 | -$1.24 | -$1.55 | -$15.33 |
| Weighted Avg Shares Outstanding | $1.34M | $1.05M | $1.05M | $1.03M |
| Weighted Avg Shares Outstanding (Diluted) | $1.34M | $1.05M | $1.05M | $1.05M |
The company's financials show resilient growth, with revenue advancing from -$33.59M in Q4 2024 to $3.16M in Q3 2025. Gross profit remained healthy with margins at 49% in Q3 2025 compared to 21% in Q4 2024. Operating income hit -$3.59M last quarter, sustaining a consistent -114% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$3.59M. Net income dropped to -$3.83M, while earnings per share reached -$2.87. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan